Une décennie ratée dans la guerre aux drogues

Cette conférence a pour but d'encourager un échange d'idées sur les politiques et pratiques relatives aux politiques de contrôle des drogues au niveau multilatéral et de discuter de l'impact des politiques répressives sur les drogues sur les mandats de la Genève internationale. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Auditorium Ivan Pictet B

Maison de la paix, Geneva

In 2009, UN member states set 2019 as the target date for eradicating the illegal drug market. Next year, the international community will take stock of progress and delineate the global drug strategy for the next decade. In the absence of a formal review for the last 10 years of drug control, the International Drug Policy Consortium (IDPC) has produced a civil society shadow report, which assesses the progress made, or lack thereof, against the objectives of 2009. The analysis shows that the scale of drug cultivation, production, trafficking and use has increased exponentially over the past decade, and the negative impacts on human rights have been severe. This conference aims to encourage an exchange of ideas on policy and practice regarding drug control policies at the multilateral level and discuss how punitive drug policies impact the International Geneva mandates. Panel discussion 

• Helen Clark, Former Prime Minister of New Zealand and former Administrator of the United Nations Development Programme, Member of the Global Commission on Drug Policy
• Ann Fordham, Executive Director of the International Drug Policy Consortium
• Mohammad-Mahmoud Ould Mohamedou, Professor, International History, the Graduate Institute, Geneva
• Anya Sarang, President of the Andrey Rylkov Foundation
• Valentin Zellweger, Ambassador, Permanent Representative of Switzerland to the United Nations Office at Geneva

Moderator: Stéphane Bussard, Reporter, Le Temps This conference is organised in partnership with the Global Commission on Drug Policy and with the support of Le Temps and the International Drug Policy Consortium.